Sarah M. Romano's Insider Trades & SAST Disclosures

Sarah M. Romano's most recent trade in Entero Therapeutics Inc. was a trade of 727 Common Stock done at an average price of $0.6 . Disclosure was reported to the exchange on Jan. 6, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Entero Therapeutics Inc.
Sarah M. Romano Chief Financial Officer 06 Jan 2025 727 17,287 (0%) 0% 0.6 465 Common Stock
Entero Therapeutics Inc.
Sarah M. Romano Chief Financial Officer 09 Oct 2024 476 18,014 (0%) 0% 0.4 212 Common Stock
Entero Therapeutics Inc.
Sarah M. Romano Chief Financial Officer 02 Jul 2024 621 18,490 (0%) 0% 1.1 664 Common Stock
First Wave BioPharma Inc
Sarah M. Romano Chief Financial Officer Sale of securities on an exchange or to another person at price $ 4.23 per share. 01 Apr 2024 75 19,111 (0%) 0% 4.2 317 Common Stock
First Wave BioPharma Inc
Sarah M. Romano Chief Financial Officer Sale of securities on an exchange or to another person at price $ 4.96 per share. 15 Mar 2024 1,120 19,186 (0%) 0% 5.0 5,555 Common Stock
First Wave BioPharma Inc
Sarah M. Romano Chief Financial Officer Sale of securities on an exchange or to another person at price $ 4.20 per share. 12 Jan 2024 98 20,306 (0%) 0% 4.2 412 Common Stock
First Wave BioPharma Inc
Sarah Romano M. Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Dec 2023 12,614 13,404 (0%) 0% 0 Common Stock
First Wave BioPharma Inc
Sarah M. Romano Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Dec 2023 7,000 20,404 (0%) 0% 0 Common Stock
First Wave BioPharma Inc
Sarah M. Romano Chief Financial Officer Sale of securities on an exchange or to another person at price $ 1.54 per share. 03 Jul 2023 1,977 17,476 (0%) 0% 1.5 3,045 Common Stock
First Wave BioPharma Inc
Sarah M. Romano Chief Financial Officer Sale of securities on an exchange or to another person at price $ 2.50 per share. 03 Apr 2023 1,975 19,453 (0%) 0% 2.5 4,938 Common Stock
First Wave BioPharma Inc
Sarah M. Romano Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2023 150,000 150,000 (0%) 0% 0 Common Stock
First Wave BioPharma Inc
Sarah M. Romano Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2022 150,000 150,000 - - Stock option (right to buy)
Kiora Pharmaceuticals Inc
Sarah M. Romano Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2022 50,000 50,000 - - Stock Option (right to buy)
Kiora Pharmaceuticals Inc
Sarah M. Romano Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.08 per share. 05 Jan 2022 114 22,854 (0%) 0% 1.1 123 Common Stock
Kiora Pharmaceuticals Inc
Sarah M. Romano Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.30 per share. 07 Dec 2021 91 22,968 (0%) 0% 1.3 118 Common Stock
Kiora Pharmaceuticals Inc
Sarah M. Romano Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.98 per share. 02 Nov 2021 83 23,059 (0%) 0% 2.0 164 Common Stock
Kiora Pharmaceuticals Inc
Sarah M. Romano Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.01 per share. 04 Oct 2021 83 23,142 (0%) 0% 2.0 167 Common Stock
Kiora Pharmaceuticals Inc
Sarah M. Romano Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.81 per share. 02 Sep 2021 84 23,225 (0%) 0% 1.8 152 Common Stock
Kiora Pharmaceuticals Inc
Sarah M. Romano Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.40 per share. 03 Aug 2021 87 23,309 (0%) 0% 2.4 209 Common Stock
Kiora Pharmaceuticals Inc
Sarah M. Romano Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.70 per share. 02 Jul 2021 180 23,396 (0%) 0% 3.7 666 Common Stock
Kiora Pharmaceuticals Inc
Sarah M. Romano Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.19 per share. 04 Jun 2021 180 23,576 (0%) 0% 4.2 754 Common Stock
Kiora Pharmaceuticals Inc
Sarah M. Romano Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.13 per share. 04 May 2021 177 23,756 (0%) 0% 4.1 731 Common Stock
Kiora Pharmaceuticals Inc
Sarah M. Romano Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.94 per share. 08 Apr 2021 180 23,933 (0%) 0% 4.9 889 Common Stock
Kiora Pharmaceuticals Inc
Sarah M. Romano Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.46 per share. 03 Mar 2021 218 24,113 (0%) 0% 5.5 1,190 Common Stock
Kiora Pharmaceuticals Inc
Sarah M. Romano Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Feb 2021 30,000 30,000 - - Stock Option (right to buy)
Kiora Pharmaceuticals Inc
Sarah M. Romano Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.34 per share. 01 Feb 2021 1,282 24,331 (0%) 0% 6.3 8,128 Common Stock
Kiora Pharmaceuticals Inc
Sarah M. Romano Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.85 per share. 04 Jan 2021 115 25,613 (0%) 0% 4.9 558 Common Stock
Kiora Pharmaceuticals Inc
Sarah M. Romano Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.51 per share. 02 Nov 2020 97 25,819 (0%) 0% 3.5 340 Common Stock
Kiora Pharmaceuticals Inc
Sarah M. Romano Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.88 per share. 02 Oct 2020 98 25,916 (0%) 0% 3.9 380 Common Stock
Kiora Pharmaceuticals Inc
Sarah M. Romano Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.94 per share. 02 Sep 2020 97 26,014 (0%) 0% 3.9 382 Common Stock
Kiora Pharmaceuticals Inc
Sarah M. Romano Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.11 per share. 04 Aug 2020 95 26,111 (0%) 0% 4.1 390 Common Stock
Kiora Pharmaceuticals Inc
Sarah M. Romano Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.82 per share. 02 Jul 2020 97 26,206 (0%) 0% 4.8 468 Common Stock
Kiora Pharmaceuticals Inc
Sarah M. Romano Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.11 per share. 03 Jun 2020 94 26,303 (0%) 0% 5.1 480 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades